Mather Group’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-294,318
| Closed | -$13.8M | – | 36 |
|
|
2015
Q3 | $13.8M | Buy |
294,318
+28,908
| +11% | +$1.36M | 3.64% | 12 |
|
|
2015
Q2 | $16.4M | Hold |
265,410
| – | – | 4.32% | 7 |
|
|
2015
Q1 | $16.4M | Buy |
265,410
+11,288
| +4% | +$697K | 4.32% | 7 |
|
|
2014
Q4 | $13.7M | Buy |
254,122
+3,782
| +2% | +$204K | 3.95% | 13 |
|
|
2014
Q3 | $13.3M | Buy |
250,340
+11,804
| +5% | +$626K | 4.08% | 9 |
|
|
2014
Q2 | $12.4M | Buy |
238,536
+23,234
| +11% | +$1.21M | 4.02% | 9 |
|
|
2014
Q1 | $10.1M | Sell |
215,302
-19,322
| -8% | -$904K | 3.7% | 11 |
|
|
2013
Q4 | $10.3M | Buy |
234,624
+4,436
| +2% | +$195K | 3.93% | 10 |
|
|
2013
Q3 | $8.86M | Buy |
230,188
+2,102
| +0.9% | +$80.9K | 3.68% | 11 |
|
|
2013
Q2 | $8.04M | Buy |
+228,086
| New | +$8.04M | 3.47% | 13 |
|